CLINICAL TRIALS PROFILE FOR OSPEMIFENE

All Clinical Trials for Ospemifene

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00276094 ↗	A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women	Completed	Hormos Medical	Phase 3	2006-01-01	The purpose of this study is to determine whether ospemifene is more effective than placebo in the treatment of vulvar and vaginal atrophy (VVA) in postmenopausal women.
NCT00276094 ↗	A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women	Completed	QuatRx Pharmaceuticals	Phase 3	2006-01-01	The purpose of this study is to determine whether ospemifene is more effective than placebo in the treatment of vulvar and vaginal atrophy (VVA) in postmenopausal women.
NCT00276094 ↗	A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women	Completed	Shionogi	Phase 3	2006-01-01	The purpose of this study is to determine whether ospemifene is more effective than placebo in the treatment of vulvar and vaginal atrophy (VVA) in postmenopausal women.
NCT00566982 ↗	A Clinical Study to Evaluate the Safety of Ospemifene	Completed	Hormos Medical	Phase 3	2007-10-01	The purpose of this study is to determine the efficacy and long-term safety of 60mg ospemifene in the treatment of VVA in postmenopausal women with intact uterus.
NCT00566982 ↗	A Clinical Study to Evaluate the Safety of Ospemifene	Completed	QuatRx Pharmaceuticals	Phase 3	2007-10-01	The purpose of this study is to determine the efficacy and long-term safety of 60mg ospemifene in the treatment of VVA in postmenopausal women with intact uterus.

Clinical Trial Conditions for Ospemifene

Condition Name

Condition Name for Ospemifene
Intervention	Trials
Atrophy	6
Vaginal Diseases	6
Vulvovaginal Atrophy	1
Vulvovaginal Signs and Symptoms	1

Condition MeSH

Condition MeSH for Ospemifene
Intervention	Trials
Atrophy	7
Vaginal Diseases	6
Disease	1
Sexual Dysfunction, Physiological	1

Clinical Trial Locations for Ospemifene

Trials by Country

Trials by Country for Ospemifene
Location	Trials
United States	31
Spain	1

Trials by US State

Trials by US State for Ospemifene
Location	Trials
Georgia	2
California	2
Kansas	1
Louisiana	1
Maine	1

Clinical Trial Progress for Ospemifene

Clinical Trial Phase

Clinical Trial Phase for Ospemifene
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	6
Phase 2	1

Clinical Trial Status

Clinical Trial Status for Ospemifene
Clinical Trial Phase	Trials
Completed	8
Recruiting	1
Terminated	1

Clinical Trial Sponsors for Ospemifene

Sponsor Name

Sponsor Name for Ospemifene
Sponsor	Trials
Shionogi	7
QuatRx Pharmaceuticals	6
Hormos Medical	4

Sponsor Type

Sponsor Type for Ospemifene
Sponsor	Trials
Industry	17
Other	3